Sofia Altuna-Venegas1, Raul Aliaga-Vega2, Jorge L Maguiña2, Jose F Parodi3, Fernando M Runzer-Colmenares4. 1. Universidad Peruana de Ciencias Aplicadas, Escuela de Medicina, Lima, Peru. Electronic address: u201113425@upc.edu.pe. 2. Universidad Peruana de Ciencias Aplicadas, Escuela de Medicina, Lima, Peru. 3. Universidad de San Martin de Porres, Facultad de Medicina Humana, Centro de investigación del evejecimiento (CIEN), Lima, Peru; Bamboo Senior Health Services, Lima, Peru. 4. Universidad de San Martin de Porres, Facultad de Medicina Humana, Centro de investigación del evejecimiento (CIEN), Lima, Peru; Universidad Científica del Sur, Lima, Peru.
Abstract
INTRODUCTION: Sarcopenia is a geriatric syndrome characterized by loss of muscle mass and strength. The prevalence in people between 60-70 years is about 5-13% and in adults over 80 years, between 11-50% in the USA. Sarcopenia increases the risk of mortality and nosocomial infections. Community-acquired pneumonia is the first infectious-related cause of death in elderly people. However, there is lack of evidence about the association between sarcopenia and pneumonia. The aim of our study was to determine the incidence and risk factors of community-acquired pneumonia in older adults with sarcopenia in a Peruvian hospital. METHODS: A retrospective cohort study was conducted in the geriatrics service of Centro Medico Naval "Cirujano Mayor Santiago Tavara". Sarcopenia was defined by "European Consensus of Sarcopenia" criteria. MultivariatePoisson regression model was conducted to estimate the effect of the independent association between sarcopenia and pneumonia. RESULTS: A total of 1598 subjects were enrolled, 59.0% were male; with a mean age of 78.3 ± 8.6 years. The prevalence of sarcopenia was 15.1% (95% CI: 13.3-16.8) and the incidence of community-acquired pneumonia was 15.14% (95%CI 13.4-16.9). In the multivariate model, we found a higher incidence of pneumonia in sarcopenic compared to non-sarcopenic, RR(a) 3.88 (95% CI: 2.82-5.33). DISCUSSION: Our study showed a higher incidence of community-acquired pneumonia in sarcopenic subject. Results provide information on the importance of detecting this syndrome because it gives us scientific evidence of the interest of a correct comprehensive geriatric assessment in older patients with a high risk of pneumonia.
INTRODUCTION: Sarcopenia is a geriatric syndrome characterized by loss of muscle mass and strength. The prevalence in people between 60-70 years is about 5-13% and in adults over 80 years, between 11-50% in the USA. Sarcopenia increases the risk of mortality and nosocomial infections. Community-acquired pneumonia is the first infectious-related cause of death in elderly people. However, there is lack of evidence about the association between sarcopenia and pneumonia. The aim of our study was to determine the incidence and risk factors of community-acquired pneumonia in older adults with sarcopenia in a Peruvian hospital. METHODS: A retrospective cohort study was conducted in the geriatrics service of Centro Medico Naval "Cirujano Mayor Santiago Tavara". Sarcopenia was defined by "European Consensus of Sarcopenia" criteria. MultivariatePoisson regression model was conducted to estimate the effect of the independent association between sarcopenia and pneumonia. RESULTS: A total of 1598 subjects were enrolled, 59.0% were male; with a mean age of 78.3 ± 8.6 years. The prevalence of sarcopenia was 15.1% (95% CI: 13.3-16.8) and the incidence of community-acquired pneumonia was 15.14% (95%CI 13.4-16.9). In the multivariate model, we found a higher incidence of pneumonia in sarcopenic compared to non-sarcopenic, RR(a) 3.88 (95% CI: 2.82-5.33). DISCUSSION: Our study showed a higher incidence of community-acquired pneumonia in sarcopenic subject. Results provide information on the importance of detecting this syndrome because it gives us scientific evidence of the interest of a correct comprehensive geriatric assessment in older patients with a high risk of pneumonia.
Authors: R Riquelme; A Torres; M El-Ebiary; J P de la Bellacasa; R Estruch; J Mensa; J Fernández-Solá; C Hernández; R Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 1996-11 Impact factor: 21.405
Authors: Robert W Krell; Daniel R Kaul; Andrew R Martin; Michael J Englesbe; Christopher J Sonnenday; Shijie Cai; Preeti N Malani Journal: Liver Transpl Date: 2013-10-21 Impact factor: 5.799
Authors: Francesco Landi; Alfonso J Cruz-Jentoft; Rosa Liperoti; Andrea Russo; Silvia Giovannini; Matteo Tosato; Ettore Capoluongo; Roberto Bernabei; Graziano Onder Journal: Age Ageing Date: 2013-01-15 Impact factor: 10.668
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: José F Parodi; Wendy Nieto-Gutierrez; Walter A Tellez; Iris Ventocilla-Gonzales; Fernando M Runzer-Colmenares; Alvaro Taype-Rondan Journal: Rev Esp Geriatr Gerontol Date: 2017-09-08
Authors: Fernando M Runzer-Colmenares; Rafael Samper-Ternent; Soham Al Snih; Kenneth J Ottenbacher; José F Parodi; Rebeca Wong Journal: Arch Gerontol Geriatr Date: 2013-08-08 Impact factor: 3.250
Authors: Olga Ochoa-Gondar; Angel Vila-Córcoles; Cinta de Diego; Victoria Arija; Monica Maxenchs; Montserrat Grive; Enrique Martin; Josep L Pinyol Journal: BMC Public Health Date: 2008-06-27 Impact factor: 3.295
Authors: Kang Lip Kim; Gi-Young Park; Dong Rak Kwon; Do Yun Kwon; Sang Gyu Kwak; Hee Kyung Cho Journal: Medicine (Baltimore) Date: 2020-11-06 Impact factor: 1.817